{"transactions":[{"id":3994893,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-03-16T01:13:06.000Z","date":"2018-03-12","kind":"exercise","acquired":false,"shares":6586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":3.41,"exercise_date":"2011-05-22","expiration_date":"2018-05-22","underlying":"Common Stock, par value $0.01 per share","underlying_shares":6586},"source":{"system":"sec-edgar","filing":"0001209191-18-020046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118020046/doc4.xml","form_type":"4"}},{"id":3994892,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T01:13:06.000Z","date":"2018-03-14","kind":"sale","acquired":false,"shares":22250,"price":4.58,"value":101905.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes (a) a deferred stock award of 17,200 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 94,185 shares of common stock held by the Reporting Person."}],"balance_after":142685,"source":{"system":"sec-edgar","filing":"0001209191-18-020046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118020046/doc4.xml","form_type":"4"}},{"id":3994891,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T01:13:06.000Z","date":"2018-03-12","kind":"tax_withholding","acquired":false,"shares":4679,"price":4.8,"value":22459.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) a deferred stock award of 17,200 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 116,435 shares of common stock held by the Reporting Person."}],"balance_after":164935,"source":{"system":"sec-edgar","filing":"0001209191-18-020046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118020046/doc4.xml","form_type":"4"}},{"id":3994890,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-16T01:13:06.000Z","date":"2018-03-12","kind":"exercise","acquired":true,"shares":6586,"price":3.41,"value":22458.26,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) a deferred stock award of 17,200 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 121,114 shares of common stock held by the Reporting Person."}],"balance_after":169614,"source":{"system":"sec-edgar","filing":"0001209191-18-020046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118020046/doc4.xml","form_type":"4"}},{"id":4001344,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-12T21:26:46.000Z","date":"2018-03-07","kind":"sale","acquired":false,"shares":35054,"price":4.61,"value":161598.94,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.50 to $4.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 17,200 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 114,528 shares of common stock held by the Reporting Person."}],"balance_after":163028,"source":{"system":"sec-edgar","filing":"0001209191-18-018913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118018913/doc4.xml","form_type":"4"}},{"id":4108048,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T13:47:43.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":17200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 17,200 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2018. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 17,200 restricted stock units which vest quarterly in equal installments on March 31, 2018, June 30, 2018, September 30, 2018 and December 31, 2018; (b) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; and (c) 149,582 shares of common stock held by the Reporting Person."}],"balance_after":198082,"source":{"system":"sec-edgar","filing":"0001209191-18-001624","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919118001624/doc4.xml","form_type":"4"}},{"id":4212860,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":21213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":2.56,"exercise_date":"2016-06-01","expiration_date":"2022-06-01","underlying":"Common Stock, par value $0.01 per share","underlying_shares":21213},"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212859,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":22545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":2.59,"exercise_date":"2014-06-04","expiration_date":"2020-06-04","underlying":"Common Stock, par value $0.01 per share","underlying_shares":22545},"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212858,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"exercise","acquired":false,"shares":23720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Represent the exercise of stock options granted pursuant to the Issuer's 2000 Stock Option and Incentive Plan, as amended."}],"balance_after":0,"derivative":{"exercise_price":2.28,"exercise_date":"2013-05-21","expiration_date":"2019-05-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":23720},"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212857,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"tax_withholding","acquired":false,"shares":16709,"price":3.25,"value":54304.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 138,432 shares of common stock held by the Reporting Person."}],"balance_after":180882,"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212856,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":21213,"price":2.56,"value":54305.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 155,141 shares of common stock held by the Reporting Person."}],"balance_after":197591,"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212855,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"tax_withholding","acquired":false,"shares":17967,"price":3.25,"value":58392.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 133,928 shares of common stock held by the Reporting Person."}],"balance_after":176378,"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212854,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":22545,"price":2.59,"value":58391.55,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 151,895 shares of common stock held by the Reporting Person."}],"balance_after":194345,"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212853,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"tax_withholding","acquired":false,"shares":16640,"price":3.25,"value":54080.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares of common stock that the Reporting Person attested to the ownership thereof in accordance with the Issuer's Third Amended and Restated 2000 Stock Option and Incentive Plan, as amended, in connection with the payment of the option exercise price. With respect to each option exercise, the Issuer only delivered the net amount of the option shares (after reducing the option shares by the amount of shares subject to such attestation) to the Reporting Person and such attestation shares were not sold by the Reporting Person or delivered to the Issuer. Nevertheless, the SEC deems such exercise and related attestation to be a disposition of shares for purposes of Section 16(a) of the Securities Exchange Act of 1934."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 129,350 shares of common stock held by the Reporting Person."}],"balance_after":171800,"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4212852,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-09-11T20:04:29.000Z","date":"2017-09-07","kind":"exercise","acquired":true,"shares":23720,"price":2.28,"value":54081.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 11,150 restricted stock units which vest quarterly in equal installments on September 30, 2017 and December 31, 2017; and (c) 145,990 shares of common stock held by the Reporting Person."}],"balance_after":188440,"source":{"system":"sec-edgar","filing":"0001209191-17-052216","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117052216/doc4.xml","form_type":"4"}},{"id":4301565,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-31T00:38:03.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":31300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 31,300 restricted stock units which fully vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 16,725 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 116,695 shares of common stock held by the Reporting Person."}],"balance_after":164720,"source":{"system":"sec-edgar","filing":"0001209191-17-036300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117036300/doc4.xml","form_type":"4"}},{"id":4503703,"issuer":{"id":7369,"kind":"organization","name":"HARVARD BIOSCIENCE INC"},"owners":[{"id":168287,"kind":"person","name":"UVEGES GEORGE","position":1,"cik":"0001124927","reported_name":"UVEGES GEORGE","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-04T21:58:40.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":22300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a deferred stock award of 22,300 restricted stock units which vest quarterly in equal installments on March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017, and are subject to continued service as a non-employee director on the applicable vesting dates. These retainer awards are granted in lieu and satisfaction of the annual cash retainer compensation to be earned by the director for his service on the Issuer's Board of Directors and its Committees during 2017. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the retainers all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of November, rounded to the nearest 100 shares."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes (a) a deferred stock award of 22,300 restricted stock units which vest quarterly in equal installments on March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017; (b) a deferred stock award of 25,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after July 1, 2016, immediately prior to the commencement of such meeting, and (ii) July 1, 2017; and (c) 85,820 shares of common stock held by the Reporting Person."}],"balance_after":133420,"source":{"system":"sec-edgar","filing":"0001209191-17-001111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1123494/000120919117001111/doc4.xml","form_type":"4"}}]}